Are respiratory physicians adherent to guidelines when evaluating pulmonary nodules?
Internal Medicine Journal · 2026-08 · 56 (8) · 1412-1420
DOI: 10.1111/imj.70491 ↗Kurz gefasst
Leitlinie in der Zeitschrift Internal Medicine Journal, online erschienen am 03.06.2026. Verfasst von Laura Tu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory & Sleep Medicine, Austin Health, Heidelberg, Victoria, Australia. Hauptthemen laut MEDLINE: Guideline Adherence, Lung Neoplasms, Pulmonologists, Solitary Pulmonary Nodule. Die Arbeit nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Introduction
Although fewer than 1% of pulmonary nodules are malignant, appropriate evaluation is essential in optimising patient outcomes. The 2017 Fleischner Society Guidelines provide recommendations on management of incidentally detected nodules; however, studies to date have shown variable guideline adherence. Adherence to guidelines in Australian nodule clinics has not been reported.
Methods
A retrospective analysis of medical records was conducted for new patients evaluated in a pulmonary nodule clinic between 1 July 2017 and 1 July 2020. Patient demographics, past medical history, family history of malignancy, smoking history, baseline lung function tests, reasons for referral and lung nodule characteristics were analysed. Follow‐up recommendations were evaluated to determine Guideline adherence. Final diagnoses, where available, were extracted from multidisciplinary meeting (MDM) data.
Results
Three hundred sixty‐one patients were included (mean age 68.2 years, female 44.3%). One hundred ten patients (30.5%) were never smokers, 106 (29.3%) current smokers, and 140 (38.8%) former smokers. Most lung nodules were identified incidentally (77.0%) with mean diameter (±SD) 12.1 ± 6.4 mm averaged from the long and short axes. Adherence to guidelines was 97.2%. Ninety‐seven patients (26.9%) were diagnosed with malignancy. Among patients diagnosed with lung cancer, former smokers had a higher risk (48.1%, relative risk (RR) 1.8; 95% confidence interval (CI) 1.08–3.1; P = 0.02) of lung cancer than never smokers (20.3%), with current smokers being intermediate in risk (31.6%, RR 1.6; 95% CI 0.96–2.84; P = 0.07).
Conclusion
Our findings from this first‐in‐Australia study demonstrate appropriate lung nodule follow‐up in accordance with Fleischner Society Guidelines in a dedicated respiratory physician‐led nodule clinic.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Respiratory & Sleep Medicine, Austin Health, Heidelberg, Victoria, Australia.
- Institute for Breathing & Sleep, Austin Health, Heidelberg, Victoria, Australia.
- Department of Medicine, University of Melbourne, Melbourne, Victoria, Australia.
- Department of Radiology, Austin Health, Heidelberg, Victoria, Australia.
ORCID-Profile: Laura Tu, Christine F McDonald
Zitieren
APA
Tu, L., Wong, R., Baker, A., O'Donoghue, F., McDonald, C. F., & Leong, T. L. (2026). Are respiratory physicians adherent to guidelines when evaluating pulmonary nodules?. Internal Medicine Journal, 56(8), 1412-1420. https://doi.org/10.1111/imj.70491
Vancouver
Tu L, Wong R, Baker A, O'Donoghue F, McDonald CF, Leong TL. Are respiratory physicians adherent to guidelines when evaluating pulmonary nodules?. Internal Medicine Journal. 2026;56(8):1412-1420. doi:10.1111/imj.70491
BibTeX
@article{Tu2026,
author = {Tu, Laura and Wong, Raymond and Baker, Amy and O'Donoghue, Fergal and McDonald, Christine F and Leong, Tracy L},
title = {Are respiratory physicians adherent to guidelines when evaluating pulmonary nodules?},
journal = {Internal Medicine Journal},
year = {2026},
volume = {56},
number = {8},
pages = {1412--1420},
doi = {10.1111/imj.70491}
}
EUVIMED